Table 1.

Genetically engineered measles virus used for oncolytic virotherapy.

Cancer Type	Genetically Modified Virus
Blood Cancer	MV-CD20, MV-PNP, MV-LacZ
Breast Cancer	MV-NAP, MV-CEA
Ovarian Cancer	MV-CD38, MV-her/neu, MV-CEA, MV-NIS
Liver Cancer	MV-CD133, MV-MMP, MV-CEA, NV-NIS
Pancreatic Cancer	MV-PNP, MV-NIS
Colorectal Cancer	MV-CD133, MV-NIS, MV-PNP
Prostate Cancer	MV-NIS, MV-CEA
Brain Cancer	MV-CD38, MV-CD133
Skin Cancer	MV-alphaPDL1
Thyroid Cancer	MV-NIS
Myeloma	MV-NIS, MV-lambda, MV-CD38
Fibrosarcoma	MV-MMP, MV-CD20
Burkitt's Lymphoma	MV-GMCSF
Lung Cancer	MV-CEA, rMV-EGFP-SLAMblind
Mesothelioma	MV-NIS, MV-GMCSF